Brief: Cantargia Announces New Nadunolimab Clinical Trial In Leukemia Financed By External US Grant

Cantargia AB

18/09/2023 06:35

Sept 18 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA ANNOUNCES NEW NADUNOLIMAB CLINICAL TRIAL IN
LEUKEMIA
FINANCED BY EXTERNAL US GRANT
    * AWARD OF A $1.1 MILLION GRANT FROM US DEPARTMENT OF
DEFENSE
    * TRIAL MAY INCLUDE A TOTAL OF 40 PATIENTS
    * PRIMARY OBJECTIVE OF THIS INVESTIGATOR-INITIATED TRIAL IS
TO
ASSESS SAFETY OF DIFFERENT DOSE LEVELS OF NADUNOLIMAB

Source text for Eikon:  ID:nMFND51Yn 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))